Eriksson M - Search Results

1

Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.

Eriksson M, Taskinen M, Leppä S. Eriksson M, et al. J Cell Physiol. 2007 Feb;210(2):538-48. doi: 10.1002/jcp.20907. J Cell Physiol. 2007. PMID: 17111371

2

Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cells.

Eriksson M, Leppä S. Eriksson M, et al. J Biol Chem. 2002 May 3;277(18):15992-6001. doi: 10.1074/jbc.M107340200. Epub 2002 Mar 7. J Biol Chem. 2002. PMID: 11884386 Free article.

3

AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells.

Eriksson M, Arminen L, Karjalainen-Lindsberg ML, Leppä S. Eriksson M, et al. Exp Cell Res. 2005 Mar 10;304(1):175-86. doi: 10.1016/j.yexcr.2004.10.017. Epub 2004 Nov 18. Exp Cell Res. 2005. PMID: 15707584

4

Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.

Joensuu H, Anttonen A, Eriksson M, Mäkitaro R, Alfthan H, Kinnula V, Leppä S. Joensuu H, et al. Among authors: eriksson m. Cancer Res. 2002 Sep 15;62(18):5210-7. Cancer Res. 2002. PMID: 12234986

5

Activator protein-1 in human male germ cell apoptosis.

Suomalainen L, Dunkel L, Ketola I, Eriksson M, Erkkilä K, Oksjoki R, Taari K, Heikinheimo M, Pentikäinen V. Suomalainen L, et al. Among authors: eriksson m. Mol Hum Reprod. 2004 Oct;10(10):743-53. doi: 10.1093/molehr/gah094. Epub 2004 Aug 6. Mol Hum Reprod. 2004. PMID: 15299089

6

The cyclo-oxygenase 2 promoter is induced in nontarget cells following adenovirus infection, but an AU-rich 3'-untranslated region destabilization element can increase specificity.

Särkioja M, Hakkarainen T, Eriksson M, Ristimäki A, Desmond RA, Kanerva A, Hemminki A. Särkioja M, et al. Among authors: eriksson m. J Gene Med. 2008 Jul;10(7):744-53. doi: 10.1002/jgm.1193. J Gene Med. 2008. PMID: 18338835

7

Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.

Bauerschmitz GJ, Ranki T, Kangasniemi L, Ribacka C, Eriksson M, Porten M, Herrmann I, Ristimäki A, Virkkunen P, Tarkkanen M, Hakkarainen T, Kanerva A, Rein D, Pesonen S, Hemminki A. Bauerschmitz GJ, et al. Among authors: eriksson m. Cancer Res. 2008 Jul 15;68(14):5533-9. doi: 10.1158/0008-5472.CAN-07-5288. Cancer Res. 2008. PMID: 18632604

8

Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells.

Eriksson M, Guse K, Bauerschmitz G, Virkkunen P, Tarkkanen M, Tanner M, Hakkarainen T, Kanerva A, Desmond RA, Pesonen S, Hemminki A. Eriksson M, et al. Mol Ther. 2007 Dec;15(12):2088-93. doi: 10.1038/sj.mt.6300300. Epub 2007 Sep 11. Mol Ther. 2007. PMID: 17848962 Free article.

9

Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer.

Sarkioja M, Kanerva A, Salo J, Kangasniemi L, Eriksson M, Raki M, Ranki T, Hakkarainen T, Hemminki A. Sarkioja M, et al. Among authors: eriksson m. Cancer. 2006 Oct 1;107(7):1578-88. doi: 10.1002/cncr.22209. Cancer. 2006. PMID: 16948124 Free article.

10

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures.

Dias JD, Guse K, Nokisalmi P, Eriksson M, Chen DT, Diaconu I, Tenhunen M, Liikanen I, Grénman R, Savontaus M, Pesonen S, Cerullo V, Hemminki A. Dias JD, et al. Among authors: eriksson m. Eur J Cancer. 2010 Feb;46(3):625-35. doi: 10.1016/j.ejca.2009.11.005. Epub 2009 Dec 16. Eur J Cancer. 2010. PMID: 20006487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,036 results

Search Page